Mathis, T.; Papegaey, M.; Ricard, C.; Rezkallah, A.; Matonti, F.; Sudhalkar, A.; Vartin, C.; Dot, C.; Kodjikian, L.
Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant for Chronic Diabetic Macular Edema Previously Treated in Real-Life Practice: The REALFAc Study. Pharmaceutics 2022, 14, 723.
https://doi.org/10.3390/pharmaceutics14040723
AMA Style
Mathis T, Papegaey M, Ricard C, Rezkallah A, Matonti F, Sudhalkar A, Vartin C, Dot C, Kodjikian L.
Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant for Chronic Diabetic Macular Edema Previously Treated in Real-Life Practice: The REALFAc Study. Pharmaceutics. 2022; 14(4):723.
https://doi.org/10.3390/pharmaceutics14040723
Chicago/Turabian Style
Mathis, Thibaud, Maxence Papegaey, Cécile Ricard, Amina Rezkallah, Frédéric Matonti, Aditya Sudhalkar, Cristina Vartin, Corinne Dot, and Laurent Kodjikian.
2022. "Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant for Chronic Diabetic Macular Edema Previously Treated in Real-Life Practice: The REALFAc Study" Pharmaceutics 14, no. 4: 723.
https://doi.org/10.3390/pharmaceutics14040723
APA Style
Mathis, T., Papegaey, M., Ricard, C., Rezkallah, A., Matonti, F., Sudhalkar, A., Vartin, C., Dot, C., & Kodjikian, L.
(2022). Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant for Chronic Diabetic Macular Edema Previously Treated in Real-Life Practice: The REALFAc Study. Pharmaceutics, 14(4), 723.
https://doi.org/10.3390/pharmaceutics14040723
